Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes: A Target Trial Emulation

NCT07513259 is registered in ClinicalTrials.gov with Chung Shan Medical University as lead sponsor.

NCT NCT07513259
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07513259 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes: A Target Trial Emulation
Lead sponsor
Chung Shan Medical University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
October 31, 2025
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus type 2, neoplasms, obesity & overweight